Funding for this research was provided by:
National Institute of Nursing Research (NR014200-01)
Text and Data Mining valid from 2018-05-10
Received: 20 September 2017
Accepted: 30 April 2018
First Online: 10 May 2018
Ethics approval and consent to participate
: All three phases or the project were approved in 2012 by Institutional Review Boards of University of Michigan and Johns Hopkins University. Written consent was obtained from all caregiver-subjects, and from all PLWD-subjects who could provide informed consent. If the PLWD was unable to provide informed consent, then proxy consent from the family caregiver (and assent from the person with dementia) was obtained.
: Not applicable.
: The authors declare they have no competing interests with the exception of CGL:C.G.L. receives grant support (research or CME) from NIMH, NIA, Associated Jewish Federation of Baltimore, Weinberg Foundation, Forest, Glaxo-Smith-Kline, Eisai, Pfizer, Astra-Zeneca, Lilly, Ortho-McNeil, Bristol-Myers, Novartis, National Football League, Elan,Functional Neuromodulation. He is also Consultant/Advisor to Astra-Zeneca, Glaxo-Smith Kline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, Lilly, Pfizer, Genentech, Elan, NFL Players Association, NFL Benefits Office, Avanir, Zinfandel, BMS,Abvie, Janssen, Orion, Otsuka, Astellas. He also receives Honorarium or travel support from Pfizer, Forest, Glaxo-Smith Kline, Health Monitor.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.